A Global Cancer Project Map Integrating Global Cancer Statistics to Guide International Efforts

Ali CHISTI, 1) Global Oncology, Inc., 2) University of Hawaii John A. Burns School of Medicine, United States
CRAYCROFT J. 1, 3 , GUPTA M. 1, 4 , SHARARA N. 1 , ROSENBERG I. 1 , SILVA J. 1 , HUANG F. 1, 3 , BHATT A. 1, 5 , MORGAN C. 6 , DUNCAN K. 6 , SILKENSEN S. 6 , ABUDU R. 7 , TRIMBLE T. 6

1 Global Oncology, Inc., Boston, MA
2 University of Hawaii John A. Burns School of Medicine, Honolulu, HI
3 Dana-Farber Cancer Institute, Boston, MA
4 Broad Institute, Cambridge, MA
5 Stanford University, Palo Alto, CA
6 Center for Global Health, National Cancer Institute, Washington DC
7 Leidos Biomed, Washington DC

Purpose 
In response to the growing burden of cancer, Global Oncology, Inc., and the National Cancer Institute Center for Global Health launched a free, online, interactive map, the Global Cancer Project Map (GCPM) [http://gcpm.globalonc.org], to allow policy makers, researchers, and civil society around the world to search this central repository of international cancer control and research projects. The GCPM serves to catalyze collaboration in cancer research and clinical care, as well as inform research and care gaps.

Methods 
In addition to search options by project attributes, the GCPM provides map overlays of epidemiological measures using IARC’s GLOBOCAN cancer-specific estimates of incidence, prevalence, and mortality, cancer disability-adjusted life-years, and UN Human Development Index country values. Currently, the map displays projects with international collaborators collated from the NCI, NCI-Designated Cancer Centers, UICC and ASCO.

Results 
The GCPM search options offer countless angles of looking at projects worldwide. Of the 1479 currently-mapped projects, 44.8% have investigators or collaborators in less-developed countries (LDCs) (as defined by the UN). Of the 1218 with a project type classification, 104 relate to capacity building and/or training, with 69 of these projects (66.3%) occurring in LDCs. Utilizing the cancer type search options, the GCPM currently displays 54 cervical cancer projects with LDC collaborators, where the cervical cancer mortality age-standardized risk is more than 2.5 times higher for LDCs than more-developed countries.

Conclusions 
The GCPM is a real-time needs assessment tool to allow the cancer community to visualize international efforts in cancer control and link need to action. To better address the growing burden of cancer, the partnership is actively seeking collaboration and additional project submissions. Utilized with cancer statistic overlays, the GCPM can help develop regional priorities in cancer research and control.

Funding 
NCI Contract No. HHSN261200800001E and resourced by in-kind volunteer hours of Global Oncology members.